Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

NCT05080660 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis
Osteo Arthritis Knee

Interventions

DRUG: LY3526318
DRUG: Placebo

Sponsor

Eli Lilly and Company